↓ Skip to main content

Effect of a daily dose of Lactobacillus brevis CD2 lozenges in high caries risk schoolchildren

Overview of attention for article published in Clinical Oral Investigations, May 2013
Altmetric Badge

Mentioned by

twitter
1 X user
video
1 YouTube creator

Citations

dimensions_citation
56 Dimensions

Readers on

mendeley
112 Mendeley
Title
Effect of a daily dose of Lactobacillus brevis CD2 lozenges in high caries risk schoolchildren
Published in
Clinical Oral Investigations, May 2013
DOI 10.1007/s00784-013-0980-9
Pubmed ID
Authors

Guglielmo Campus, Fabio Cocco, Giovanna Carta, Maria Grazia Cagetti, Charlotte Simark-Mattson, Laura Strohmenger, Peter Lingström

Abstract

A double-blind, randomised, placebo-controlled clinical trial was performed to validate the hypothesis that the use of lozenges containing Lactobacillus brevis CD2 (Inersan®, CD Investments srl) may reduce plaque pH, salivary mutans streptococci (ms) and bleeding on probing, during a 6-week period, in a sample of high caries risk schoolchildren.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 112 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 112 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 13%
Student > Bachelor 13 12%
Researcher 12 11%
Student > Ph. D. Student 10 9%
Student > Postgraduate 6 5%
Other 22 20%
Unknown 34 30%
Readers by discipline Count As %
Medicine and Dentistry 44 39%
Agricultural and Biological Sciences 10 9%
Biochemistry, Genetics and Molecular Biology 8 7%
Immunology and Microbiology 5 4%
Nursing and Health Professions 3 3%
Other 5 4%
Unknown 37 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 October 2018.
All research outputs
#17,687,671
of 22,709,015 outputs
Outputs from Clinical Oral Investigations
#747
of 1,390 outputs
Outputs of similar age
#138,529
of 192,919 outputs
Outputs of similar age from Clinical Oral Investigations
#9
of 14 outputs
Altmetric has tracked 22,709,015 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,390 research outputs from this source. They receive a mean Attention Score of 3.6. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 192,919 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.